CVS Suspends Zantac Sales
A popular pharmacy chain is pulling a heartburn drug off the shelves over cancer concerns. CVS has stopped selling Zantac in addition to its own generic version of the medication after the US Food and Drug Administration discovered that acid-reducing medicines with Ranitidine contain low levels of an impurity that could cause cancer.
Although the pharmacy chain has decided to stop selling the medicine, Zantac and its generic counterpart have not been recalled. Customers who have already brought the products from CVS can return them for a full refund.